50
Participants
Start Date
July 1, 2024
Primary Completion Date
July 30, 2027
Study Completion Date
November 30, 2027
MRI
Patients will get special MRI sequences (CO2-triggered BOLD MRI, Vessel-wall imaging, resting state BOLD MRI) to identify cerebral vasoreactivity and disease activity.
H2 15O PET/CT
Patients will get H2 15O PET/CT with acetazolamide challenge to define the cerebral vasoreserve for comparison with fMRI Images
Biosampling
Patients do get a venous puncture for blood analysis on circulating endothelial cells and virus PCR analysis
RECRUITING
University of Tuebingen, Neurosurgery, Tübingen
University Hospital Freiburg
OTHER
University Hospital Tuebingen
OTHER